9-(1,1-Dioxidotetrahydrothiophen-3-yl)-3-(4-methoxyphenyl)-9,10-dihydro-4H,8H-chromeno[8,7-e][1,3]oxazin-4-one

Catalog No. :
ACGVAC282
CAS No. :
946385-19-9
Molecular Formula :
C22H21NO6S
Molecular Weight :
427.48

IUPAC Name:9-(1,1-dioxidotetrahydrothiophen-3-yl)-3-(4-methoxyphenyl)-9,10-dihydro-4H,8H-chromeno[8,7-e][1,3]oxazin-4-one

9-(1,1-Dioxidotetrahydrothiophen-3-yl)-3-(4-methoxyphenyl)-9,10-dihydro-4H,8H-chromeno[8,7-e][1,3]oxazin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name9-(1,1-Dioxidotetrahydrothiophen-3-yl)-3-(4-methoxyphenyl)-9,10-dihydro-4H,8H-chromeno[8,7-e][1,3]oxazin-4-one
IUPAC Name9-(1,1-dioxidotetrahydrothiophen-3-yl)-3-(4-methoxyphenyl)-9,10-dihydro-4H,8H-chromeno[8,7-e][1,3]oxazin-4-one
Molecular FormulaC22H21NO6S
Molecular Weight427.48
SMILESO=C1C(C2=CC=C(OC)C=C2)=COC3=C4CN(C(CC5)CS5(=O)=O)COC4=CC=C31
InChI KeyUTXFTKCIURXJII-UHFFFAOYSA-N
Synonym9-(1,1-dioxothiolan-3-yl)-3-(4-methoxyphenyl)-8,10-dihydropyrano[2,3-f][1,3]benzoxazin-4-one;4H,8H-Pyrano[2,3-f][1,3]benzoxazin-4-one, 9,10-dihydro-3-(4-methoxyphenyl)-9-(tetrahydro-1,1-dioxido-3-thienyl)-
CAS No.946385-19-9

Synthetic Route by SureRoute

1. ACGVAC282 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFPSA972 route compound structure diagram
    ACFPSA9725720-07-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGVAC282 route product structure diagram
    ACGVAC282946385-19-9
Inquiry

2. ACGVAC282 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFPSA972 route compound structure diagram
    ACFPSA9725720-07-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGVAC282 route product structure diagram
    ACGVAC282946385-19-9
Inquiry

Comments (0)